Helicobacter pylori infection. B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: Intervention group A: Patients will receive synbiotics for the first two weeks and the second two weeks. Intervention 2: Control group: Patients who will receive placebo in the first t
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Consent to participate in the study Patients over 18 years of age with H. pylori infection for which the infection has been proven for the first time No history of recent treatment failure Absence of any serious underlying disease such as neoplasms, gastric ulcers, dementia, and Alzheimer's disease
Exclusion criteria
Exclusion criteria: Allergies or side effects related to medications used in the study Taking antibiotics at the same time during the course
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of Helicobacter pylori infection. Timepoint: 4 weeks after completion of standard treatment course. Method of measurement: Helicobacter pylori fecal antigen testing. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence to treatment. Timepoint: On days 14 and 28 after starting treatment. Method of measurement: Counting unused medications.;Side effects of disease and medication. Timepoint: Before intervention and on days 14, 28, and 42. Method of measurement: Short questionnaire.;Patient demographic information including age, gender, underlying disease, etc. Timepoint: Before the intervention. Method of measurement: Short questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Reesi
Shahre-kord University of Medical Sciences
Outcome results
None listed